| Towards the sustainable discovery and development of new antibiotics M Miethke, M Pieroni, T Weber, M Brönstrup, P Hammann, L Halby, ... Nat Rev Chem 5, 726-749, 2021 | 873 | 2021 |
| Comparative genomics of the major parasitic worms IHG Consortium Nature Genetics, 2018 | 435* | 2018 |
| Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study A Hoerauf, S Specht, M Büttner, K Pfarr, S Mand, R Fimmers, ... Medical microbiology and immunology 197, 295-311, 2008 | 322 | 2008 |
| Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis AY Debrah, S Mand, S Specht, Y Marfo-Debrekyei, L Batsa, K Pfarr, ... PLoS pathogens 2 (9), e92, 2006 | 260 | 2006 |
| Doxycycline as a novel strategy against bancroftian filariasis—depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production A Hoerauf, S Mand, K Fischer, T Kruppa, Y Marfo-Debrekyei, AY Debrah, ... Medical microbiology and immunology 192, 211-216, 2003 | 235 | 2003 |
| Filariasis and lymphoedema KM Pfarr, AY Debrah, S Specht, A Hoerauf Parasite immunology 31 (11), 664-672, 2009 | 219 | 2009 |
| Filariasis in Africa—treatment challenges and prospects A Hoerauf, K Pfarr, S Mand, AY Debrah, S Specht Clinical Microbiology and Infection 17 (7), 977-985, 2011 | 175 | 2011 |
| Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti AY Debrah, S Mand, Y Marfo‐Debrekyei, L Batsa, K Pfarr, M Buttner, ... Tropical medicine & international health 12 (12), 1433-1441, 2007 | 149 | 2007 |
| A Randomized, Double-Blind Clinical Trial of a 3-Week Course of Doxycycline plus Albendazole and Ivermectin for the Treatment of Wuchereria bancrofti Infection JD Turner, S Mand, AY Debrah, J Muehlfeld, K Pfarr, HF McGarry, O Adjei, ... Clinical Infectious Diseases 42 (8), 1081-1089, 2006 | 147 | 2006 |
| Extracellular Onchocerca-derived small RNAs in host nodules and blood JF Quintana, BL Makepeace, SA Babayan, A Ivens, KM Pfarr, M Blaxter, ... Parasites & vectors 8, 1-11, 2015 | 138 | 2015 |
| Evidence against Wolbachia symbiosis in Loa loa HF McGarry, K Pfarr, G Egerton, A Hoerauf, JP Akue, P Enyong, S Wanji, ... Filaria journal 2, 1-7, 2003 | 124 | 2003 |
| Doxycycline Treatment of Brugia malayi—Infected Persons Reduces Microfilaremia and Adverse Reactions after Diethylcarbamazine and Albendazole Treatment T Supali, Y Djuardi, KM Pfarr, H Wibowo, MJ Taylor, A Hoerauf, ... Clinical infectious diseases 46 (9), 1385-1393, 2008 | 122 | 2008 |
| Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine S Mand, K Pfarr, PK Sahoo, AK Satapathy, S Specht, U Klarmann, ... The American journal of tropical medicine and hygiene, 2009 | 96 | 2009 |
| Functional conservation of the lipid II biosynthesis pathway in the cell wall‐less bacteria Chlamydia and Wolbachia: why is lipid II needed? B Henrichfreise, A Schiefer, T Schneider, E Nzukou, C Poellinger, ... Molecular microbiology 73 (5), 913-923, 2009 | 94 | 2009 |
| Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis AY Debrah, S Mand, MR Toliat, Y Marfo-Debrekyei, L Batsa, P Nürnberg, ... American Journal of Tropical Medicine and Hygiene 77 (4), 601, 2007 | 94 | 2007 |
| Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with … AY Debrah, S Mand, Y Marfo-Debrekyei, L Batsa, K Pfarr, B Lawson, ... The American journal of tropical medicine and hygiene 80 (6), 956-963, 2009 | 85 | 2009 |
| Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species) J Gilbert, CK Nfon, BL Makepeace, LM Njongmeta, IM Hastings, KM Pfarr, ... The Journal of infectious diseases 192 (8), 1483-1493, 2005 | 84 | 2005 |
| Corallopyronin A Specifically Targets and Depletes Essential Obligate Wolbachia Endobacteria From Filarial Nematodes In Vivo A Schiefer, A Schmitz, TF Schäberle, S Specht, C Lämmer, KL Johnston, ... The Journal of infectious diseases 206 (2), 249-257, 2012 | 83 | 2012 |
| Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis KL Johnston, L Ford, I Umareddy, S Townson, S Specht, K Pfarr, ... International Journal for Parasitology: Drugs and Drug Resistance 4 (3), 278-286, 2014 | 75 | 2014 |
| Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: A case–control study R Colebunders, M Mandro, JL Mokili, G Mucinya, G Mambandu, K Pfarr, ... International Journal of Infectious Diseases 49, 1-8, 2016 | 68 | 2016 |
Achim HoeraufProfessor für Medizinische Mikrobiologie und Parasitologie, Unversitätsklinikum BonnVerified email at uni-bonn.de